A Biotechnology Engineering Center Opens in Kazan
Yesterday in Kazan within the framework of celebration of the 10th anniversary of Technopolis ChemGrad a Biotechnology Engineering Center was inaugurated, which will soon start to manufacture drugs from the VED list used in transplantology, oncology and for treatment of HIV.
The new Laboratory and research complex will develop and issue drugs based on biopolymers, micro and nanoparticles, as well as potent drugs for treatment of cancers, HIV infections and drugs used in organ transplant.
Orest Ibragimov, Director of Nanopharma Development, a Technopolis resident, remarked that the production capacity is sufficient to cover the needs for drugs used in transplantology by 50% and for drugs for HIV – by 20-25%, for treatment of cancers – by 10%.
The project involves generic drugs that passed all stages of preclinical and clinical trials, that proved full equivalence to original drugs and non inferior efficacy and safety. The drugs will be 30-35% less expensive than original drugs.
Currently the project involves imatinib (original drug Glivec), civalgan (Valcyte) and tacrolimus (Prograf). Besides, in 2017-2018 manufacture of nine drugs will be launched: three – for treatment of HIV, five antineoplastic drugs and one drug used for transplantation.